MARKET

IGC

IGC

IGC Pharma Inc
AMEX
0.2804
-0.0021
-0.74%
After Hours: 0.2800 -0.0004 -0.14% 16:10 06/12 EDT
OPEN
0.2825
PREV CLOSE
0.2825
HIGH
0.2946
LOW
0.2800
VOLUME
548.02K
TURNOVER
--
52 WEEK HIGH
0.4985
52 WEEK LOW
0.2420
MARKET CAP
28.07M
P/E (TTM)
-4.3881
1D
5D
1M
3M
1Y
5Y
1D
IGC Pharma reaches 146-patient enrollment target for Phase 2 Calma trial
TipRanks · 1d ago
IGC Pharma Extends and Amends $12 Million Loan Facility
TipRanks · 4d ago
Weekly Report: what happened at IGC last week (0601-0605)?
Weekly Report · 4d ago
IGC Pharma Price Target Raised to $5.50/Share From $5.25 by Ascendiant Capital
Dow Jones · 4d ago
IGC Pharma Is Maintained at Buy by Ascendiant Capital
Dow Jones · 4d ago
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5.5
Benzinga · 4d ago
'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment
Benzinga · 06/05 11:56
IGC Pharma adds Mount Sinai clinical site as CALMA trial advances
TipRanks · 06/02 15:20
More
About IGC
IGC Pharma, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) to develop treatments for Alzheimer's and metabolic disorders. The Company's lead asset, IGC-AD1, is a cannabinoid-based therapy is in a Phase 2 trial (CALMA) for agitation in Alzheimer's dementia. The Company’s pipeline includes TGR-63, targeting amyloid plaques, and early-stage programs focused on neurodegeneration, tau proteins, and metabolic dysfunctions. The Company integrates AI to accelerate drug discovery, optimize clinical trials, and enhance patient targeting. It is also developing a Multimodal Interpretable Transformer for Alzheimer’s Disease (MINT-AD). MINT-AD leverages diverse data sources, including brain scans, genetics, lifestyle, and cognitive metrics, to produce clinically interpretable risk profiles and forecast decline trajectories.

Webull offers IGC Pharma Inc stock information, including AMEX: IGC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IGC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IGC stock methods without spending real money on the virtual paper trading platform.